Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Common Stock | Options Exercise | +3.35K | +23.59% | 17.5K | Jan 15, 2025 | Direct | F1 | ||
transaction | GBIO | Common Stock | Tax liability | -$1.03K | -1.16K | -6.62% | $0.89 | 16.4K | Jan 15, 2025 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -3.35K | -10% | $0.00 | 30.1K | Jan 15, 2025 | Common Stock | 3.35K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
F2 | The grant of 53,550 restricted stock units was made on April 5, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on April 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. |